18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats
about
In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensisBrain regions mediating alpha3beta4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administrationThe anti-addiction drug ibogaine and the heart: a delicate relation18-methoxycoronaridine: a potential new treatment for obesity in rats?Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration18-Methoxycoronaridine blocks context-induced reinstatement following cocaine self-administration in ratsNoribogaine reduces nicotine self-administration in rats.Novel pharmacotherapeutic treatments for cocaine addiction.Clinical applications of hallucinogens: A review.Traditional medicine in the treatment of drug addiction.The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seekingRecent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior.Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administrationα3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo.18-Methoxycoronaridine, a potential anti-obesity agent, does not produce a conditioned taste aversion in rats.High affinity α3β4 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice.Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment.GDNF--a potential target to treat addiction.18-Methoxycoronaridine blocks acquisition but enhances reinstatement of a cocaine place preferenceAnti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profileNovel α3β4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluationImpact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by α3β4α5 nicotinic acetylcholine receptors.Pharmacological comparison of the effect of ibogaine and 18-methoxycoronaridine on isolated smooth muscle from the rat and guinea-pig.Pharmacotherapy: Quest for the quitting pill.Mechanisms of Antiaddictive Actions of Ibogainea.18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action.
P2860
Q24536041-6574BCE9-84C4-4B60-9EC1-A22C56C87C85Q24646664-8F8E7AE1-EEC5-4BFC-AFC3-78EC5FC2A10CQ27009689-2C74CF47-7950-4ED1-9518-9D90EBE8BE93Q28292083-EBA7B452-E37A-47C6-8954-E7AE730F68F5Q28297349-557E8EF1-31DE-43EC-A42B-E5EC568E42B9Q30420282-F3DB5CF3-49A7-4E98-85AD-5C517DF94D09Q30653279-450D23B0-645C-4C85-AC16-F4403D11EBEDQ34065088-B214A8D3-56D7-4ECA-A707-3E3B9620CBCDQ34535259-711757C5-A5E9-4682-8CA7-C629FE0FE634Q34603231-A55A1C6B-3521-4D52-82DB-202A1B8E0100Q35087497-50439F88-689A-4115-B0A9-57ECC5D1DA3BQ35184641-1F816D92-0D7A-4786-AF1F-5EA6442CA546Q35243269-E3EC99CE-0BA9-4112-BA4C-A6D5741F1DF3Q36054871-8124F4CF-3E3E-49EE-9E28-47D6A1E3A9BEQ36073986-F04050BB-2A90-49BC-BB5F-AD13CBC5DDDCQ36144918-232E7119-3D93-45B1-ACC0-43505C01FF48Q36589468-EF549DFC-5D65-4011-BD73-50FF41E6C1CAQ36928841-3CF3EB24-D67E-43E3-8D40-D678F85A226FQ37208304-18EEAD85-2DBD-4CCA-83A7-30791A23C981Q37368901-D148D554-17B3-4608-87D2-3EB9587CB8AEQ39639317-3104EE5F-B561-4089-875E-06559586C1A5Q40954873-93FADD9D-686B-4285-9748-B3DB15E22BE2Q41785459-B763CF84-BD81-4629-97F4-4A6483EDD85AQ47680460-A3701F4C-A6F9-4C11-BF4E-AD56B8FE705EQ48482237-9CEF34B1-4128-4B3A-823B-846FB15A8207Q51372570-99A654EE-6079-4EA6-914E-ACD9D32EE00E
P2860
18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
18-Methoxycoronaridine, a non- ...... imbic dopamine release in rats
@ast
18-Methoxycoronaridine, a non- ...... imbic dopamine release in rats
@en
18-Methoxycoronaridine, a non- ...... imbic dopamine release in rats
@nl
type
label
18-Methoxycoronaridine, a non- ...... imbic dopamine release in rats
@ast
18-Methoxycoronaridine, a non- ...... imbic dopamine release in rats
@en
18-Methoxycoronaridine, a non- ...... imbic dopamine release in rats
@nl
prefLabel
18-Methoxycoronaridine, a non- ...... imbic dopamine release in rats
@ast
18-Methoxycoronaridine, a non- ...... imbic dopamine release in rats
@en
18-Methoxycoronaridine, a non- ...... imbic dopamine release in rats
@nl
P2093
P921
P1433
P1476
18-Methoxycoronaridine, a non- ...... imbic dopamine release in rats
@en
P2093
H H Molinari
I M Maisonneuve
M E Kuehne
U K Bandarage
P356
10.1016/0006-8993(96)00056-X
P407
P577
1996-05-06T00:00:00Z